All Stories

  1. Pachydermoperiostosis mimicking the acral abnormalities of acromegaly

    Article • Endocrine, January 2020, Springer Science + Business Media

    Marta Korbonits

  2. Pseudoacromegaly

    Article • Frontiers in Neuroendocrinology, November 2018, Elsevier

    Marta Korbonits

  3. Coexisting pituitary and non-pituitary gigantism in the same family

    Article • Clinical Endocrinology, October 2018, Wiley

    Marta Korbonits

  4. Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome

    Article • Case Reports in Endocrinology, August 2018, Hindawi Publishing Corporation

    Marta Korbonits

  5. De novo HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesaemia

    Article • Endocrinology Diabetes and Metabolism Case Reports, March 2018, Bioscientifica

    Marta Korbonits

  6. Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members’ View in anAIPMutation-Positive Family

    Article • International Journal of Endocrinology, January 2018, Hindawi Publishing Corporation

    Marta Korbonits

  7. AIP and the somatostatin system in pituitary tumours

    Article • Journal of Endocrinology, August 2017, Bioscientifica

    Marta Korbonits

  8. Fatal Carney Complex in Siblings Due to De Novo Large Gene Deletion

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2017, Endocrine Society

    Marta Korbonits

  9. In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism

    Article • European Journal of Endocrinology, June 2017, Bioscientifica

    Marta Korbonits, Professor Lou A Metherell

  10. Pituitary Carcinoma in a Patient with an SDHB Mutation

    Article • Endocrine Pathology, March 2017, Springer Science + Business Media

    Marta Korbonits

  11. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening

    Article • Expert Review of Endocrinology & Metabolism, March 2017, Taylor & Francis

    Marta Korbonits

  12. Genetic Aspects of Pituitary Adenomas

    Article • Endocrinology and Metabolism Clinics of North America, March 2017, Elsevier

    Marta Korbonits

  13. Renin-Angiotensin System Blockade Improves Cardiac Indices in Acromegaly Patients

    Article • Experimental and Clinical Endocrinology & Diabetes, February 2017, Thieme Publishing Group

    Marta Korbonits

  14. Social, educational and vocational outcomes in patients with childhood-onset and young-adult-onset growth hormone deficiency

    Article • Clinical Endocrinology, February 2017, Wiley

    Marta Korbonits

  15. The genetic background of acromegaly

    Article • Pituitary, February 2017, Springer Science + Business Media

    Marta Korbonits

  16. Succinate Dehydrogenase B (SDHB)-Associated Bladder Paragangliomas

    Article • Clinical Genitourinary Cancer, February 2017, Elsevier

    Marta Korbonits

  17. Metformin prevents metabolic side effects during systemic glucocorticoid treatment

    Article • European Journal of Endocrinology, January 2017, Bioscientifica

    Marta Korbonits

  18. Diagnostic challenges and management of a patient with acromegaly due to ectopic growth hormone-releasing hormone secretion from a bronchial carcinoid tumour

    Article • Endocrinology Diabetes and Metabolism Case Reports, January 2017, Bioscientifica

    Marta Korbonits, Dr Robert D Murray

  19. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas

    Article • Pathology & Oncology Research, December 2016, Springer Science + Business Media

    Marta Korbonits

  20. Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers

    Article • Clinical Endocrinology, October 2016, Wiley

    Marta Korbonits

  21. The clinical, pathological and molecular differences between sparsely and densely granulated somatotroph adenomas

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  22. Glioma in an AIP mutation carrier patient

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  23. Pseudoacromegaly - a differential diagnostic problem for acromegaly

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  24. Olfactory neuroblastoma: a multi centre clinical and pathological review

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  25. Metformin alters an anti-proliferative effect of Mitotane in a human adrenocortical cancer (H295R) cell line: preliminary results

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  26. The role of the microenvironment in the invasive phenotype of familial pituitary tumours

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  27. Polymorphism or mutation? - The role of the R304Q missense AIP mutation in the predisposition to pituitary adenoma

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits, Adrian Daly

  28. ESR2 mutations in RET mutation-negative familial medullary thyroid carcinoma

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  29. Novel Genetic Causes of Pituitary Adenomas

    Article • Clinical Cancer Research, October 2016, American Association for Cancer Research (AACR)

    Marta Korbonits

  30. Increased Population Risk ofAIP-Related Acromegaly and Gigantism in Ireland

    Article • Human Mutation, October 2016, Wiley

    Marta Korbonits

  31. Gigantism: X-linked acrogigantism and GPR101 mutations

    Article • Growth Hormone & IGF Research, October 2016, Elsevier

    Marta Korbonits

  32. Characterisation of myocardial structure and function in adult-onset growth hormone deficiency using cardiac magnetic resonance

    Article • Endocrine, August 2016, Springer Science + Business Media

    Marta Korbonits

  33. Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With MissenseAIPMutations

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2016, Endocrine Society

    Professor Fulvio D'Acquisto, Marta Korbonits

  34. Signaling network map of the aryl hydrocarbon receptor

    Article • Journal of Cell Communication and Signaling, July 2016, Springer Science + Business Media

    Marta Korbonits, Professor Premendu Prakash Mathur

  35. AIP inactivation leads to pituitary enlargement in the Zebrafish embryo model

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    Marta Korbonits

  36. The Drosophila AIP orthologue is essential for actin cytoskeleton stabilisation and cell adhesion

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    Marta Korbonits

  37. cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors

    Article • Endocrine Related Cancer, May 2016, Bioscientifica

    Marta Korbonits

  38. SomaticGPR101Duplication Causing X-Linked Acrogigantism (XLAG)—Diagnosis and Management

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2016, Endocrine Society

    Marta Korbonits

  39. Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction

    Article • Journal of the American College of Cardiology, May 2016, Elsevier

    Marta Korbonits

  40. AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience

    Article • Endocrine, March 2016, Springer Science + Business Media

    Marta Korbonits

  41. Clinicopathologic features of familial pituitary adenomas

    Article • Diagnostic Histopathology, March 2016, Elsevier

    Marta Korbonits

  42. Cancerous leptomeningitis and familial congenital hypopituitarism

    Article • Endocrine, February 2016, Springer Science + Business Media

    Marta Korbonits

  43. AIP and the somatostatin signalling in pituitary tumours

    Article • Endocrine Abstracts, February 2016, Bioscientifica

    Marta Korbonits

  44. Can immediate postoperative random growth hormone levels predict long-term cure in patients with acromegaly?

    Article • Neurology India, January 2016, Medknow

    Marta Korbonits, Prof NARESH SACHDEVA

  45. Endocrine Tumor Genetics: Challenging Issues

    Article • January 2016, Endocrine Society

    Marta Korbonits

  46. Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity

    Article • World Journal of Diabetes, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Marta Korbonits

  47. Diagnosis of Acromegaly

    Article • January 2016, Elsevier

    Marta Korbonits

  48. Clinical Features of Acromegaly☆

    Article • January 2016, Elsevier

    Marta Korbonits

  49. Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly

    Article • European Journal of Endocrinology, December 2015, Bioscientifica

    Dr Niki Karavitaki, Professor Christian J. Strasburger, Marta Korbonits

  50. Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways

    Article • PLoS ONE, December 2015, PLOS

    Marta Korbonits

  51. Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

    Article • European Journal of Endocrinology, November 2015, Bioscientifica

    Marta Korbonits

  52. Childhood somatotroph pituitary adenomas due to aryl hydrocarbon receptor interacting protein (AIP) gene mutations

    Article • Endocrine Abstracts, November 2015, Bioscientifica

    Marta Korbonits

  53. Pegvisomant treatment for X-linked acrogigantism syndrome

    Article • Endocrine Abstracts, November 2015, Bioscientifica

    Marta Korbonits

  54. Achieving a consensus on managing idiopathic thickening of the pituitary stalk through a national multidisciplinary forum, meeting virtually

    Article • Endocrine Abstracts, November 2015, Bioscientifica

    Marta Korbonits, Ian Kamaly-Asl

  55. In vitroeffects of Imatinib on somatotrophinoma cell line

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits, Prof NARESH SACHDEVA

  56. Silencing of aryl hydrocarbon receptor protein (AIP) up-regulates the small Rho GTPase, CDC42

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  57. Novel targeted treatment combinations for malignant neuroendocrine tumour olfactory neuroblastoma

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  58. Potential molecular mechanism of AIP-mediated cellular invasion

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  59. The effect of AIP on AHR transcriptional activity: implications forAIPmutations pathogenicity

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  60. Investigation of the invasive phenotype of AIP-mutated pituitary adenomas

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  61. The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study

    Article • European Journal of Endocrinology, September 2015, Bioscientifica

    Marta Korbonits

  62. Histopathology and molecular characterisation of intrauterine-diagnosed congenital craniopharyngioma

    Article • Pituitary, September 2015, Springer Science + Business Media

    Marta Korbonits

  63. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis inAIPMutation Carriers

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2015, Endocrine Society

    Dr Warrick J Inder, Dr Niki Karavitaki, Marta Korbonits

  64. The effects of chronic candesartan treatment on cardiac and hepatic adenosine monophosphate-activated protein kinase in rats submitted to surgical stress

    Article • Journal of the Renin-Angiotensin-Aldosterone System, September 2015, SAGE Publications

    Marta Korbonits

  65. Prostatic hyperplasia in acromegaly

    Article • European Journal of Endocrinology, July 2015, Bioscientifica

    Dr Balan Louis Gaspar, Marta Korbonits

  66. Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1

    Article • International Journal of Pediatric Endocrinology, July 2015, Springer Science + Business Media

    Marta Korbonits

  67. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2015, Endocrine Society

    Marta Korbonits

  68. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas

    Article • Endocrine Related Cancer, June 2015, Bioscientifica

    Marta Korbonits

  69. Metabolic comorbidities in Cushing's syndrome

    Article • European Journal of Endocrinology, June 2015, Bioscientifica

    Marta Korbonits

  70. Ghrelin

    Article • Molecular Metabolism, June 2015, Elsevier

    Marta Korbonits, Inge Depoortere

  71. Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter

    Article • PLoS ONE, May 2015, PLOS

    Marta Korbonits

  72. The ubiquitin-specific protease 8 gene is frequently mutated in adenomas causing Cushing's disease

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Luis Gustavo Perez-Rivas, Marta Korbonits

  73. Pituitary apoplexy in GH-deficient adults treated with GH - a KIMS database retrospective study

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Marta Korbonits

  74. Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2015, Endocrine Society

    Marta Korbonits

  75. Excessive Growth Hormone Expression in Male GH Transgenic Mice Adversely Alters Bone Architecture and Mechanical Strength

    Article • Endocrinology, April 2015, Endocrine Society

    Marta Korbonits

  76. Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia

    Article • Endocrine, March 2015, Springer Science + Business Media

    Marta Korbonits

  77. Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2015, Endocrine Society

    Dr Christopher A Wassif, PROF CESAR L BOGUSZEWSKI, Marta Korbonits

  78. Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas

    Article • PLoS ONE, February 2015, PLOS

    Marta Korbonits

  79. Evaluation of genotype–phenotype relationships in patients referred for endocrine assessment in suspected Pendred syndrome

    Article • European Journal of Endocrinology, February 2015, Bioscientifica

    Marta Korbonits

  80. Prostatic hyperplasia in acromegaly, a myth or reality: a case–control study

    Article • European Journal of Endocrinology, February 2015, Bioscientifica

    Marta Korbonits

  81. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database

    Article • January 2015, Bioscientifica

    Marta Korbonits

  82. An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene

    Article • Endocrinology Diabetes and Metabolism Case Reports, January 2015, Bioscientifica

    Claus H. Gravholt, Marta Korbonits, Professor Jens Otto Lunde Jorgensen

  83. Multi-parametric cardiovascular magnetic resonance imaging detects subclinical myocardial involvement in patients diagnosed with phaeochromocytoma

    Article • Journal of Cardiovascular Magnetic Resonance, January 2015, Springer Science + Business Media

    Dr Niki Karavitaki, Marta Korbonits

  84. A 25-Year-Old Woman with Headache and Joint Pain

    Article • January 2015, Springer Science + Business Media

    Marta Korbonits

  85. Clinical profile and outcome of patients with acromegaly according to the 2014 consensus guidelines: Impact of a multi-disciplinary team

    Article • Neurology India, January 2015, Medknow

    Marta Korbonits, Prof NARESH SACHDEVA

  86. The role of ghrelin in weight-regulation disorders: Implications in clinical practice

    Article • HORMONES, December 2014, Hellenic Endocrine Society

    Marta Korbonits

  87. Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas

    Article • European Journal of Endocrinology, December 2014, Bioscientifica

    Dr Niki Karavitaki, Marta Korbonits

  88. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort

    Article • European Journal of Endocrinology, November 2014, Bioscientifica

    Dr Niki Karavitaki, Marta Korbonits

  89. Adrenal cancer in neurofibromatosis type 1: case report and DNA analysis

    Article • Endocrinology Diabetes and Metabolism Case Reports, November 2014, Bioscientifica

    Marta Korbonits

  90. Paediatric pituitary adenomas: rare, complex, and by no means benign

    Article • Endocrine Abstracts, October 2014, Bioscientifica

    Marta Korbonits

  91. Common Genetic Variants of the Human Steroid 21-Hydroxylase Gene (CYP21A2) Are Related to Differences in Circulating Hormone Levels

    Article • PLoS ONE, September 2014, PLOS

    Marta Korbonits

  92. Combination of 13-CisRetinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice

    Article • Endocrinology, July 2014, Endocrine Society

    Marta Korbonits

  93. Effects of Long-term Growth Hormone Replacement in Adults With Growth Hormone Deficiency Following Cure of Acromegaly: A KIMS Analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2014, Endocrine Society

    Professor Ulla Feldt-Rasmussen, Professor Gudmundur Johannsson, Marta Korbonits

  94. 122 Cardiac Abnormalities are Common in Patients Diagnosed with Phaeochromocytoma as Detected by Cardiovascular Magnetic Resonance Imaging

    Article • Heart, May 2014, BMJ

    Dr Niki Karavitaki, Marta Korbonits

  95. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations

    Article • Acta Neuropathologica, May 2014, Springer Science + Business Media

    Marta Korbonits

  96. Human AIP gene rescue lethality in a Drosophila melanogaster knockout model of AIP orthologue

    Article • Endocrine Abstracts, April 2014, Bioscientifica

    Marta Korbonits

  97. The anti-proliferative effect of anti-EGFR tyrosine kinase inhibitor in combination with mitotane on H295R adrenocortical cancer cells

    Article • Endocrine Abstracts, April 2014, Bioscientifica

    Marta Korbonits

  98. Clinical Experience in the Screening and Management of a Large Kindred With Familial Isolated Pituitary Adenoma Due to an Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutation

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2014, Endocrine Society

    Marta Korbonits

  99. Analysis of the AIP gene promoter

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Marta Korbonits

  100. Kallmann syndrome, gender dysphoria, thrombophilia and multiple sclerosis: a complex case report

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Marta Korbonits, Richard Quinton

  101. High incidence of cardiac involvement in patients diagnosed with phaeochromocytoma: a clinical study using cardiovascular magnetic resonance imaging

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Dr Niki Karavitaki, Dr Theodoros Karamitsos, Marta Korbonits

  102. RET mutation negative familial medullary thyroid carcinoma: four families and literature review

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Marta Korbonits

  103. Pre-clinical assessment of the impact of Erlotinib on adrenocortical cancer cells proliferation

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Marta Korbonits

  104. Epidemiology and etiopathogenesis of pituitary adenomas

    Article • Journal of Neuro-Oncology, January 2014, Springer Science + Business Media

    Marta Korbonits

  105. Metformin—mode of action and clinical implications for diabetes and cancer

    Article • Nature Reviews Endocrinology, January 2014, Springer Science + Business Media

    Marta Korbonits

  106. Preface

    Article • January 2014, Elsevier

    Marta Korbonits

  107. Familial pituitary tumors

    Article • January 2014, Elsevier

    Marta Korbonits

  108. Characterization of SNARE Proteins in Human Pituitary Adenomas: Targeted Secretion Inhibitors as a New Strategy for the Treatment of Acromegaly?

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2013, Endocrine Society

    Marta Korbonits

  109. MicroRNAs: Suggested role in pituitary adenoma pathogenesis

    Article • Journal of Endocrinological Investigation, November 2013, Springer Science + Business Media

    Marta Korbonits

  110. Effects of smoking cessation on  -cell function, insulin sensitivity, body weight, and appetite

    Article • October 2013, Bioscientifica

    Marta Korbonits

  111. The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release

    Article • The FASEB Journal, August 2013, Federation of American Societies For Experimental Biology (FASEB)

    Marta Korbonits

  112. CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus

    Article • July 2013, Bioscientifica

    Marta Korbonits

  113. A Comprehensive Next Generation Sequencing–Based Genetic Testing Strategy To Improve Diagnosis of Inherited Pheochromocytoma and Paraganglioma

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2013, Endocrine Society

    Marta Korbonits

  114. Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas-kidney transplantation with systemic venous insulin delivery

    Article • Clinical Endocrinology, May 2013, Wiley

    Marta Korbonits

  115. Novel pathway for somatostatin analogs in patients with acromegaly

    Article • Trends in Endocrinology and Metabolism, May 2013, Elsevier

    Marta Korbonits

  116. GH excess in bGH transgenic mice adversely affects bone density, architecture and quality

    Article • Bone Abstracts, May 2013, Bioscientifica

    Marta Korbonits

  117. AIP (aryl hydrocarbon receptor interacting protein)

    Article • Atlas of Genetics and Cytogenetics in Oncology and Haematology, May 2013, INIST-CNRS

    Marta Korbonits

  118. Gene expression profiling of familial and sporadic pituitary adenomas

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Marta Korbonits

  119. Genetic and clinical characteristics of Serbian FIPA families

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Marta Korbonits

  120. Drosophila melanogasteras a model organism to study aryl hydrocarbon receptor interacting protein gene function

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Marta Korbonits

  121. A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype

    Article • PLoS Genetics, March 2013, PLOS

    Marta Korbonits

  122. Familial Pituitary Adenomas

    Article • March 2013, Wiley

    Marta Korbonits

  123. Genes and giants

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  124. De Novo HNF1b mutation as a cause for chronic treatment-resistant hypomagnesaemia

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  125. Excessive GH expression in bGH transgenic mice adversely alters bone architecture and quality

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  126. The role of microRNA miR-34a in the regulation of aryl hydrocarbon receptor interacting protein

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  127. Invasion signature' revealed by the analysis of AIP positive and AIP mutation negative human pituitary adenomas

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  128. Creation of a locus-specific database for AIP mutations

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  129. Genetics of the Ghrelin System

    Article • January 2013, Karger Publishers

    Marta Korbonits

  130. Genetics of Pituitary Adenomas

    Article • January 2013, Karger Publishers

    Marta Korbonits

  131. Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism

    Article • Molecular and Cellular Endocrinology, January 2013, Elsevier

    Marta Korbonits

  132. Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition

    Article • PLoS ONE, December 2012, PLOS

    Marta Korbonits, Dr Chrisostomos Prodromou

  133. Familial isolated pituitary adenomas: An emerging clinical entity

    Article • Journal of Endocrinological Investigation, December 2012, Springer Science + Business Media

    Marta Korbonits

  134. ACTH-secreting Crooke cell carcinoma of the pituitary

    Article • European Journal of Clinical Investigation, November 2012, Wiley

    Marta Korbonits

  135. Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma

    Article • Arquivos Brasileiros de Endocrinologia & Metabologia, November 2012, FapUNIFESP (SciELO)

    PROF CESAR L BOGUSZEWSKI, Marta Korbonits

  136. 2.7 Expression of a subset of microRNAs in clinically non-functioning pituitary adenomas correlates with tumor size

    Article • September 2012, De Gruyter

    Marta Korbonits

  137. Familial pituitary adenomas – who should be tested for AIP mutations?

    Article • Clinical Endocrinology, August 2012, Wiley

    Marta Korbonits

  138. Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2012, Endocrine Society

    Dr Niki Karavitaki, Marta Korbonits

  139. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro

    Article • AJP Endocrinology and Metabolism, July 2012, American Physiological Society

    Marta Korbonits

  140. Oncogene-induced senescence in pituitary adenomas and carcinomas

    Article • HORMONES, July 2012, Hellenic Endocrine Society

    Marta Korbonits

  141. Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines

    Article • June 2012, Bioscientifica

    Marta Korbonits, ashley grossman

  142. Mice lacking AMP-activated protein kinase  1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment

    Article • June 2012, Bioscientifica

    Marta Korbonits

  143. Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide

    Article • May 2012, Bioscientifica

    Dr Niki Karavitaki, Marta Korbonits

  144. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis

    Article • Human Mutation, May 2012, Wiley

    Marta Korbonits

  145. Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor

    Article • Pituitary, April 2012, Springer Science + Business Media

    Marta Korbonits

  146. Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker

    Article • Stress, January 2012, Taylor & Francis

    Marta Korbonits

  147. Ghrelin Regulation of AMPK in the Hypothalamus and Peripheral Tissues

    Article • January 2012, Springer Science + Business Media

    Marta Korbonits

  148. Measurement of AMP-Activated Protein Kinase Activity and Expression in Response to Ghrelin

    Article • January 2012, Elsevier

    Marta Korbonits

  149. Cardiovascular changes in patients with adult-onset growth hormone deficiency assessed by CMR

    Article • Journal of Cardiovascular Magnetic Resonance, January 2012, Springer Science + Business Media

    Marta Korbonits, Professor Steffen E Petersen

  150. Cardiovascular changes in patients with acromegaly assessed by CMR

    Article • Journal of Cardiovascular Magnetic Resonance, January 2012, Springer Science + Business Media

    Marta Korbonits, Professor Steffen E Petersen

  151. Genetic studies on the ghrelin, growth hormone secretagogue receptor (GHSR) and ghrelin O-acyl transferase (GOAT) genes

    Article • Peptides, November 2011, Elsevier

    Marta Korbonits

  152. The Immunophilin-Like Protein XAP2 Is a Negative Regulator of Estrogen Signaling through Interaction with Estrogen Receptor α

    Article • PLoS ONE, October 2011, PLOS

    Marta Korbonits

  153. Ghrelin in obesity and endocrine diseases

    Article • Molecular and Cellular Endocrinology, June 2011, Elsevier

    Marta Korbonits

  154. miR-107 Is Overexpressed in Pituitary Adenomas and Inhibits the Expression of Aryl Hydrocarbon Receptor-Interacting Protein (AIP)

    Article • June 2011, Endocrine Society

    Marta Korbonits

  155. Familial isolated pituitary adenoma syndrome

    Article • Orvosi Hetilap, May 2011, Akademiai Kiado

    Marta Korbonits

  156. Specific electrocardiographic features associated with Cushing’s disease

    Article • Clinical Endocrinology, April 2011, Wiley

    Marta Korbonits

  157. AIP and its interacting partners

    Article • Journal of Endocrinology, March 2011, Bioscientifica

    Marta Korbonits

  158. WITHDRAWN: Ghrelin in obesity and endocrine diseases

    Article • Molecular and Cellular Endocrinology, March 2011, Elsevier

    Marta Korbonits

  159. The ghrelin/GOAT/GHS-R system and energy metabolism

    Article • Reviews in Endocrine and Metabolic Disorders, February 2011, Springer Science + Business Media

    Marta Korbonits

  160. AIPMutation in Pituitary Adenomas in the 18th Century and Today

    Article • New England Journal of Medicine, January 2011, New England Journal of Medicine (NEJM/MMS)

    Marta Korbonits

  161. 2.3.11 Acromegaly

    Article • January 2011, Oxford University Press (OUP)

    Marta Korbonits

  162. The expression of ghrelin O-acyltransferase (GOAT) in human tissues

    Article • Endocrine Journal, January 2011, Japan Endocrine Society

    Marta Korbonits

  163. Mechanisms of metformin action on glucose transport and metabolism in human adipocytes

    Article • Biochemical Pharmacology, December 2010, Elsevier

    Marta Korbonits

  164. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas

    Article • Pituitary, November 2010, Springer Science + Business Media

    Marta Korbonits

  165. Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening

    Article • Arquivos Brasileiros de Endocrinologia & Metabologia, November 2010, FapUNIFESP (SciELO)

    Marta Korbonits

  166. Down-Regulation of Wee1 Kinase by a Specific Subset of microRNA in Human Sporadic Pituitary Adenomas

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2010, Endocrine Society

    Marta Korbonits

  167. AIP gene and familial isolated pituitary adenomas

    Article • Molecular and Cellular Endocrinology, September 2010, Elsevier

    Marta Korbonits

  168. Cyclins and their related proteins in pituitary tumourigenesis

    Article • Molecular and Cellular Endocrinology, September 2010, Elsevier

    Marta Korbonits

  169. Role of the aryl hydrocarbon receptor-interacting protein in familial isolated pituitary adenoma

    Article • Expert Review of Endocrinology & Metabolism, September 2010, Taylor & Francis

    Marta Korbonits

  170. Down-Regulation of Wee1 Kinase by a Specific Subset of microRNAs in Human Sporadic Pituitary Adenomas

    Article • Molecular Endocrinology, September 2010, Endocrine Society

    Marta Korbonits

  171. Alterations in Adipose Tissue during Critical Illness

    Article • American Review of Respiratory Disease, August 2010, American Thoracic Society

    Marta Korbonits

  172. Treatment of acromegaly

    Article • Orvosi Hetilap, August 2010, Akademiai Kiado

    Marta Korbonits

  173. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass

    Article • Bone, August 2010, Elsevier

    Marta Korbonits

  174. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA)

    Article • Trends in Endocrinology and Metabolism, July 2010, Elsevier

    Marta Korbonits

  175. AMP-activated protein kinase (AMPK) regulates in vitro bone formation and bone mass in vivo

    Article • Bone, June 2010, Elsevier

    Marta Korbonits

  176. MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas

    Article • Endocrine, May 2010, Springer Science + Business Media

    Marta Korbonits

  177. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families

    Article • Human Mutation, May 2010, Wiley

    Marta Korbonits

  178. Ghrelin’s Role as a Major Regulator of Appetite and Its Other Functions in Neuroendocrinology

    Article • January 2010, Elsevier

    Marta Korbonits

  179. Molecular Genetics of the Aip Gene in Familial Pituitary Tumorigenesis

    Article • January 2010, Elsevier

    Marta Korbonits

  180. PL10 The curious case of ghrelin

    Article • Growth Hormone & IGF Research, January 2010, Elsevier

    Marta Korbonits

  181. Analysis of IMP3 Expression in Normal and Neoplastic Human Pituitary Tissues

    Article • Endocrine Pathology, November 2009, Springer Science + Business Media

    Marta Korbonits

  182. Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists

    Article • European Journal of Endocrinology, September 2009, Bioscientifica

    Marta Korbonits

  183. AMPK as a mediator of hormonal signalling

    Article • Journal of Molecular Endocrinology, July 2009, Bioscientifica

    Marta Korbonits

  184. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors

    Article • Endocrine Related Cancer, July 2009, Bioscientifica

    Marta Korbonits

  185. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes

    Article • European Journal of Endocrinology, May 2009, Bioscientifica

    Marta Korbonits

  186. Recent Clinical and Pathophysiological Advances in Non-Functioning Pituitary Adenomas

    Article • Hormone Research in Paediatrics, April 2009, Karger Publishers

    Marta Korbonits

  187. Association Studies onGhrelinandGhrelin ReceptorGene Polymorphisms With Obesity

    Article • Obesity, April 2009, Wiley

    Marta Korbonits

  188. Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation

    Article • Journal of Endocrinology, March 2009, Bioscientifica

    Marta Korbonits

  189. AIP, a Protein Mutated in Familial Acromegaly, Plays a Role in the Regulation of Cell Proliferation and Shows Cell-Type Specific Subcellular Localisation

    Article • Hormone Research in Paediatrics, January 2009, Karger Publishers

    Marta Korbonits, Dr Sevda Hassan

  190. Assessment of p27 (cyclin‐dependent kinase inhibitor 1B) and aryl hydrocarbon receptor‐interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations

    Article • Clinical Endocrinology, January 2009, Wiley

    Richard Quinton, Marta Korbonits

  191. Familial Isolated Pituitary Adenomas

    Article • touchREVIEWS in Endocrinology, January 2009, Touch Digital Media, Ltd.

    Marta Korbonits

  192. Familial Isolated Pituitary Adenomas

    Article • US Endocrinology, January 2009, Touch Digital Media, Ltd.

    Marta Korbonits

  193. A Genetic Study of the Ghrelin and Growth Hormone Secretagogue Receptor (GHSR) Genes and Stature

    Article • Annals of Human Genetics, January 2009, Wiley

    Marta Korbonits

  194. STOP AKTING TO TREAT ENDOCRINE TUMOURS

    Article • Acta Endocrinologica (Bucharest), January 2009, ACTA Endocrinologica Foundation

    Marta Korbonits

  195. The Yin and Yang of the Ghrelin Gene Products

    Article • Immunology Endocrine & Metabolic Agents - Medicinal Chemistry, December 2008, Bentham Science Publishers

    Marta Korbonits

  196. The potential role of D2 dopamine receptors as a target in the management of neuroendocrine tumors

    Article • Cancer Biology & Therapy, December 2008, Taylor & Francis

    Marta Korbonits

  197. Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2008, Endocrine Society

    Marta Korbonits

  198. Ghrelin Receptor Gene Polymorphisms and Body Size in Children and Adults

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2008, Endocrine Society

    Marta Korbonits

  199. Protein western array analysis in human pituitary tumours: insights and limitations

    Article • Endocrine Related Cancer, September 2008, Bioscientifica

    Marta Korbonits

  200. The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2008, Endocrine Society

    Richard Quinton, Marta Korbonits, Dr Sevda Hassan

  201. AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome

    Article • The FASEB Journal, June 2008, Federation of American Societies For Experimental Biology (FASEB)

    Marta Korbonits

  202. Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms

    Article • Endocrine Related Cancer, May 2008, Bioscientifica

    Marta Korbonits

  203. The role of somatostatin analogues in the treatment of neuroendocrine tumours

    Article • Molecular and Cellular Endocrinology, May 2008, Elsevier

    Marta Korbonits

  204. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients

    Article • Nephrology Dialysis Transplantation, April 2008, Oxford University Press (OUP)

    Marta Korbonits

  205. The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System

    Article • PLoS ONE, March 2008, PLOS

    Marta Korbonits

  206. The Role of AMP-Activated Protein Kinase in Obesity

    Article • January 2008, Karger Publishers

    Marta Korbonits

  207. Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line

    Article • Neuroendocrinology, January 2008, Karger Publishers

    Marta Korbonits

  208. Contents / Foreword / Preface

    Article • January 2008, Karger Publishers

    Marta Korbonits

  209. A new variation in the promoter region, the −604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance

    Article • International Journal of Obesity, December 2007, Nature

    Marta Korbonits

  210. Metabolic and hormonal changes during the refeeding period of prolonged fasting

    Article • European Journal of Endocrinology, July 2007, Bioscientifica

    Marta Korbonits

  211. Examining the Candidacy of Ghrelin as a Gene Responsible for Variation in Adult Stature in a United Kingdom Population with Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2007, Endocrine Society

    Marta Korbonits

  212. Ghrelin in neuroendocrine organs and tumours

    Article • Pituitary, May 2007, Springer Science + Business Media

    Marta Korbonits

  213. A mutation and expression analysis of the oncogene BRAF in pituitary adenomas

    Article • Clinical Endocrinology, March 2007, Wiley

    Marta Korbonits, Dr Massimiliano Ruscica

  214. Ghrelin, the peripheral hunger hormone

    Article • Annals of Medicine, January 2007, Taylor & Francis

    Marta Korbonits

  215. Appetite and Metabolic Effects of Ghrelin and Cannabinoids: Involvement of AMP-Activated Protein Kinase

    Article • January 2007, Elsevier

    Marta Korbonits

  216. The Farnesoid X Receptor Is Expressed in Breast Cancer and Regulates Apoptosis and Aromatase Expression

    Article • Cancer Research, October 2006, American Association for Cancer Research (AACR)

    Marta Korbonits

  217. PPAR-? expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-? receptor

    Article • Clinical Endocrinology, September 2006, Wiley

    Marta Korbonits

  218. Macro- and micronutrient losses and nutritional status resulting from 44 days of total fasting in a non-obese man

    Article • Nutrition, September 2006, Elsevier

    Marta Korbonits

  219. Effect of Gastric Bypass and Gastric Banding on Proneurotensin Levels in Morbidly Obese Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2006, Endocrine Society

    Marta Korbonits

  220. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours

    Article • European Journal of Endocrinology, August 2006, Bioscientifica

    Marta Korbonits

  221. Expanding role of AMPK in endocrinology

    Article • Trends in Endocrinology and Metabolism, July 2006, Elsevier

    Marta Korbonits

  222. Ghrelin and cardiovascular health

    Article • Current Opinion in Pharmacology, April 2006, Elsevier

    Marta Korbonits

  223. Refeeding David Blaine — Studies after a 44-Day Fast

    Article • New England Journal of Medicine, November 2005, New England Journal of Medicine (NEJM/MMS)

    Marta Korbonits

  224. Differential gene expression in pituitary adenomas by oligonucleotide array analysis

    Article • European Journal of Endocrinology, June 2005, Bioscientifica

    Marta Korbonits

  225. Enhanced protein kinase B/Akt signalling in pituitary tumours

    Article • Endocrine Related Cancer, June 2005, Bioscientifica

    Marta Korbonits

  226. Fasting and Postprandial Hyperghrelinemia in Prader-Willi Syndrome Is Partially Explained by Hypoinsulinemia, and Is Not Due to Peptide YY3–36Deficiency or Seen in Hypothalamic Obesity Due to Craniopharyngioma

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2005, Endocrine Society

    Marta Korbonits

  227. Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase

    Article • Journal of Biological Chemistry, April 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Marta Korbonits

  228. A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas

    Article • PLoS Genetics, January 2005, PLOS

    Marta Korbonits

  229. Striant™ SR: a novel, effective and convenient testosterone therapy for male hypogonadism

    Article • International Journal of Clinical Practice, November 2004, Wiley

    Marta Korbonits

  230. Akting and Cycling: A Tale of the Pituitary

    Article • Hormone Research in Paediatrics, November 2004, Karger Publishers

    Marta Korbonits

  231. Theobromine inhibits sensory nerve activation and cough

    Article • The FASEB Journal, November 2004, Federation of American Societies For Experimental Biology (FASEB)

    Marta Korbonits

  232. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin

    Article • British Journal of Pharmacology, November 2004, Wiley

    Marta Korbonits

  233. Ghrelin: update on a novel hormonal system

    Article • European Journal of Endocrinology, August 2004, Bioscientifica

    Marta Korbonits

  234. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway

    Article • European Journal of Endocrinology, August 2004, Bioscientifica

    Marta Korbonits

  235. A Comparison of a Novel Testosterone Bioadhesive Buccal System, Striant, with a Testosterone Adhesive Patch in Hypogonadal Males

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2004, Endocrine Society

    Marta Korbonits

  236. Ghrelin?a hormone with multiple functions

    Article • Frontiers in Neuroendocrinology, April 2004, Elsevier

    Marta Korbonits

  237. Elevated Fasting Plasma Ghrelin in Prader-Willi Syndrome Adults Is Not Solely Explained by Their Reduced Visceral Adiposity and Insulin Resistance

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2004, Endocrine Society

    Marta Korbonits

  238. Non-Growth Hormone Endocrine Actions of Ghrelin

    Article • January 2004, Springer Science + Business Media

    Marta Korbonits

  239. Identification of Adrenocorticotropin Receptor Messenger Ribonucleic Acid in the Human Pituitary and Its Loss of Expression in Pituitary Adenomas

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2003, Endocrine Society

    Marta Korbonits

  240. The Kruppel-like transcription factor 6 gene in sporadic pituitary tumours

    Article • Endocrine Related Cancer, September 2003, Bioscientifica

    Marta Korbonits

  241. Reduced expression of the growth hormone and type 1 insulin‐like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor

    Article • Clinical Endocrinology, August 2003, Wiley

    Professor Lou A Metherell, Marta Korbonits

  242. Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro

    Article • Journal of Endocrinological Investigation, August 2003, Springer Science + Business Media

    Marta Korbonits

  243. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours

    Article • Journal of Endocrinology, August 2003, Bioscientifica

    Marta Korbonits

  244. Ghrelin is Released from Rat Hypothalamic Explants and Stimulates Corticotrophin-releasing Hormone and Arginine-vasopressin

    Article • Hormone and Metabolic Research, August 2003, Thieme Publishing Group

    Marta Korbonits

  245. Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency

    Article • Clinical Endocrinology, May 2003, Wiley

    Marta Korbonits

  246. Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei

    Article • Journal of Endocrinology, January 2003, Bioscientifica

    Marta Korbonits

  247. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours

    Article • Clinical Endocrinology, September 2002, Wiley

    Marta Korbonits

  248. A Variation in the Ghrelin Gene Increases Weight and Decreases Insulin Secretion in Tall, Obese Children

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2002, Endocrine Society

    Marta Korbonits

  249. A Variation in the Ghrelin Gene Increases Weight and Decreases Insulin Secretion in Tall, Obese Children

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2002, Endocrine Society

    Marta Korbonits

  250. Cell Cycle Dysregulation in Human Pituitary Tumours

    Article • Clinical Science, July 2002, Portland Press Ltd.

    Marta Korbonits

  251. The Tissue Distribution of the mRNA of Ghrelin and Subtypes of Its Receptor, GHS-R, in Humans

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Marta Korbonits

  252. Expression of Phosphorylated p27Kip1Protein and Jun Activation Domain-Binding Protein 1 in Human Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Marta Korbonits

  253. Expression of Phosphorylated p27Kip1 Protein and Jun Activation Domain-Binding Protein 1 in Human Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Marta Korbonits

  254. The Tissue Distribution of the mRNA of Ghrelin and Subtypes of Its Receptor, GHS-R, in Humans

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Marta Korbonits

  255. Optimal Response Criteria for the Human CRH Test in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2002, Endocrine Society

    Marta Korbonits

  256. Response of Serum Macrophage Migration Inhibitory Factor Levels to Stimulation or Suppression of the Hypothalamo-Pituitary-Adrenal Axis in Normal Subjects and Patients with Cushing's Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2002, Endocrine Society

    Marta Korbonits

  257. Article • Pituitary, January 2002, Springer Science + Business Media

    Marta Korbonits

  258. The Effect of Growth Hormone Secretagogues and Neuropeptide Y on Hypothalamic Hormone Release from Acute Rat Hypothalamic Explants

    Article • Journal of Neuroendocrinology, December 2001, Wiley

    Marta Korbonits

  259. The release of leptin and its effect on hormone release from human pituitary adenomas

    Article • Clinical Endocrinology, June 2001, Wiley

    Marta Korbonits

  260. Expression of 11β-Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2001, Endocrine Society

    Marta Korbonits

  261. Ghrelin, the endogenous ligand to the growth hormone secretagogue receptor — expression in human hypothalamus and pituitary

    Article • Growth Hormone & IGF Research, June 2001, Elsevier

    Marta Korbonits

  262. Expression of 11 -Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2001, Endocrine Society

    Marta Korbonits

  263. Imprinting of the Gsα gene GNAS1 in the pathogenesis of acromegaly

    Article • Journal of Clinical Investigation, March 2001, American Society for Clinical Investigation

    Marta Korbonits

  264. The Expression of the Growth Hormone Secretagogue Receptor Ligand Ghrelin in Normal and Abnormal Human Pituitary and Other Neuroendocrine Tumors1

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2001, Endocrine Society

    Marta Korbonits

  265. Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2001, Endocrine Society

    Marta Korbonits

  266. The Expression of the Growth Hormone Secretagogue Receptor Ligand Ghrelin in Normal and Abnormal Human Pituitary and Other Neuroendocrine Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2001, Endocrine Society

    Marta Korbonits

  267. Presence of Ghrelin in Normal and Adenomatous Human Pituitary

    Article • Endocrine, January 2001, Springer Science + Business Media

    Marta Korbonits

  268. Article • Pituitary, January 2001, Springer Science + Business Media

    Marta Korbonits

  269. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?

    Article • Clinical Endocrinology, October 2000, Wiley

    Marta Korbonits

  270. Expression of the Pituitary Transcription Factor Ptx-1, But Not That of theTrans-Activating Factor Prop-1, Is Reduced in Human Corticotroph Adenomas and Is Associated with Decreasedα -Subunit Secretion1

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2000, Endocrine Society

    Marta Korbonits

  271. Expression of the Pituitary Transcription Factor Ptx-1, But Not That of the Trans-Activating Factor Prop-1, Is Reduced in Human Corticotroph Adenomas and Is Associated with Decreased  -Subunit Secretion

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2000, Endocrine Society

    Marta Korbonits

  272. Low Expression of the Cell Cycle Inhibitor p27Kip1in Normal Corticotroph Cells, Corticotroph Tumors, and Malignant Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1999, Endocrine Society

    Marta Korbonits

  273. Hexarelin as a test of pituitary reserve in patients with pituitary disease

    Article • Clinical Endocrinology, September 1999, Wiley

    Marta Korbonits

  274. The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1999, Endocrine Society

    Marta Korbonits

  275. The growth hormone secretagogue receptor

    Article • Growth Hormone & IGF Research, April 1999, Elsevier

    Marta Korbonits

  276. Expression of menin gene mRNA in pituitary tumours

    Article • European Journal of Endocrinology, April 1999, Bioscientifica

    Marta Korbonits

  277. The Effects of GH-Secretagogues on Human Pituitary Cells in Culture and on Rat Hypothalamic Tissue

    Article • January 1999, Elsevier

    Marta Korbonits

  278. Leptin and the thyroid — A puzzle with missing pieces

    Article • Clinical Endocrinology, November 1998, Wiley

    Marta Korbonits

  279. Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors1

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1998, Endocrine Society

    Marta Korbonits

  280. Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1998, Endocrine Society

    Marta Korbonits

  281. The Pathophysiology of Circulating Corticotropin-Releasing Hormone-Binding Protein Levels in the Human

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1998, Endocrine Society

    Marta Korbonits

  282. Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary‐adrenal activity

    Article • Clinical Endocrinology, June 1997, Wiley

    Marta Korbonits

  283. Differential stimulation of corticol and dehydropiandrosterone levels by food in obese and normal subjects: relation to body fat distribution

    Article • Clinical Endocrinology, December 1996, Wiley

    Marta Korbonits

  284. Intérêt clinique des neuropeptides GHRH et GHRP

    Article • Archives de Pédiatrie, January 1996, Elsevier

    Marta Korbonits

  285. Diagnosis of Growth Hormone Deficiency in Adults

    Article • Hormone Research, January 1996, Karger Publishers

    Marta Korbonits

  286. The effect of an opiate antagonist on the hormonal changes induced by hexarelin

    Article • Clinical Endocrinology, September 1995, Wiley

    Marta Korbonits

  287. Growth hormone-releasing peptide and its analogues

    Article • Trends in Endocrinology and Metabolism, March 1995, Elsevier

    Marta Korbonits

  288. Determination of Direct Effects of Cytokines on Release of Neuropeptides from Rat Hypothalamus by an in Vitro Method

    Article • January 1993, Elsevier

    Marta Korbonits